BANCFIRST CORP /OK/ Stock Compensation Disclosure
(13) STOCK-BASED COMPENSATION
On May 25, 2023, the stockholders of the Company adopted the BancFirst Corporation 2023 Restricted Stock Unit Plan (the "RSU Plan"). The RSU Plan was effective as of June 1, 2023 and for a period of ten years thereafter. The RSU Plan will continue in effect after such ten-year period until all matters relating to the payment of awards and administration of the RSU Plan have been settled. At December 31, 2025 there were 428,175 shares available for future grants. The restricted stock units ("RSU's") vest beginning two years from the date of grant at the rate of 20% per year for five years. The RSU's are settled and distributed as of each vesting date. The fair value of each RSU granted is equal to the market price of the Company’s stock at the date of grant.
The following table is a summary of the activity under the Company's RSU plan.
|
|
|
|
|
|
|
||
|
|
|
|
|
Wgtd. Avg. |
|
||
|
|
Restricted |
|
|
Grant Date |
|
||
|
|
Stock Units |
|
|
Fair Value |
|
||
Year Ended December 31, 2025 |
|
|
|
|
|
|
||
Nonvested at December 31, 2024 |
|
|
42,825 |
|
|
$ |
90.35 |
|
Granted |
|
|
31,000 |
|
|
|
124.77 |
|
Vested |
|
|
(6,115 |
) |
|
|
87.40 |
|
Forfeited |
|
|
(2,000 |
) |
|
|
121.42 |
|
Nonvested at December 31, 2025 |
|
|
65,710 |
|
|
|
105.92 |
|
|
|
|
|
|
|
|
||
Year Ended December 31, 2024 |
|
|
|
|
|
|
||
Nonvested at December 31, 2023 |
|
|
32,075 |
|
|
$ |
87.23 |
|
Granted |
|
|
12,250 |
|
|
|
97.71 |
|
Forfeited |
|
|
(1,500 |
) |
|
|
83.61 |
|
Nonvested at December 31, 2024 |
|
|
42,825 |
|
|
|
90.35 |
|
The Company has had the BancFirst Corporation Directors’ Deferred Stock Compensation Plan (the “Deferred Stock Compensation Plan”) since May 1999. As of December 31, 2025, there are 27,328 shares available for future issuance under the Deferred Stock Compensation Plan. The Deferred Stock Compensation Plan will terminate on December 31, 2030 if not extended. Under the plan, directors and members of the community advisory boards of the Company and its subsidiaries may defer up to 100% of their board fees. They are credited for each deferral with a number of stock units based on the current market price of the Company’s stock, which accumulate in an account until such time as the director or community board member terminates serving as a board member. Shares of common stock of the Company are then distributed to the terminating director or community board member based upon the number of stock units accumulated in his or her account. There were 6,462 and 7,031 shares of common stock distributed from the Deferred Stock Compensation Plan during the years ended December 31, 2025 and 2024, respectively.
A summary of the accumulated stock units under the Deferred Stock Compensation Plan is as follows:
|
|
December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Accumulated stock units |
|
|
122,841 |
|
|
|
120,984 |
|
Average price |
|
$ |
50.50 |
|
|
$ |
44.70 |
|
The Company terminated the BancFirst Corporation Stock Option Plan (the “Employee Plan”), on June 1, 2023. The remaining options will continue to vest and are exercisable beginning four years from the date of grant at the rate of 25% per year for four years, and expire no later than the end of fifteen years from the date of grant.
The Company terminated the BancFirst Corporation Non-Employee Directors’ Stock Option Plan (the “Non-Employee Directors’ Plan”), on June 1, 2023. The remaining options will continue to vest and are exercisable beginning one year from the date of grant at the rate of 25% per year for four years, and expire no later than the end of fifteen years from the date of grant.
The following table is a summary of the activity under both the Employee Plan and the Non-Employee Directors’ Plan:
|
|
|
|
|
|
|
|
Wgtd. Avg. |
|
|
|
|||
|
|
|
|
|
Wgtd. Avg. |
|
|
Remaining |
|
Aggregate |
|
|||
|
|
|
|
|
Exercise |
|
|
Contractual |
|
Intrinsic |
|
|||
|
|
Options |
|
|
Price |
|
|
Term |
|
Value |
|
|||
|
|
(Dollars in thousands, except option data) |
|
|||||||||||
Year Ended December 31, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|||
Outstanding at December 31, 2024 |
|
|
947,921 |
|
|
$ |
58.42 |
|
|
|
|
|
|
|
Options exercised |
|
|
(105,701 |
) |
|
|
42.45 |
|
|
|
|
|
|
|
Options canceled, forfeited, or expired |
|
|
(12,000 |
) |
|
|
89.02 |
|
|
|
|
|
|
|
Outstanding at December 31, 2025 |
|
|
830,220 |
|
|
|
60.01 |
|
|
9.04Yrs |
|
$ |
38,197 |
|
Exercisable at December 31, 2025 |
|
|
387,970 |
|
|
|
47.29 |
|
|
7.23Yrs |
|
$ |
22,784 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Year Ended December 31, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|||
Outstanding at December 31, 2023 |
|
|
1,241,391 |
|
|
$ |
53.12 |
|
|
|
|
|
|
|
Options exercised |
|
|
(276,470 |
) |
|
|
32.60 |
|
|
|
|
|
|
|
Options canceled, forfeited, or expired |
|
|
(17,000 |
) |
|
|
91.32 |
|
|
|
|
|
|
|
Outstanding at December 31, 2024 |
|
|
947,921 |
|
|
|
58.42 |
|
|
9.70Yrs |
|
$ |
55,700 |
|
Exercisable at December 31, 2024 |
|
|
361,921 |
|
|
|
42.20 |
|
|
6.98Yrs |
|
$ |
27,136 |
|
The following table has additional information regarding options exercised under both the Employee Plan and the Non-Employee Directors’ Plan:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
|
|
(Dollars in thousands) |
|
|||||||||
Total intrinsic value of options exercised |
|
$ |
9,025 |
|
|
$ |
20,373 |
|
|
$ |
3,055 |
|
Cash received from options exercised |
|
|
4,487 |
|
|
|
9,013 |
|
|
|
2,090 |
|
Tax benefit realized from options exercised |
|
|
4,170 |
|
|
|
4,497 |
|
|
|
734 |
|
The Company currently uses newly issued shares for stock-based compensation plans, but reserves the right to use shares purchased under the Company’s Stock Repurchase Program (the “SRP”) in the future.
Although not required or expected, the Company may settle some options or restricted stock units in cash on a limited basis at the discretion of the Company. The Company had no cash settlements during the years ended December 31, 2025, 2024 and 2023.
Stock-based compensation expense is charged to salaries and benefits expense on the Consolidated Statements of Comprehensive Income. The components of stock-based compensation expense for all share-based compensation plans and related tax benefits are as follows:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
|
|
(Dollars in thousands) |
|
|||||||||
Stock-based compensation expense |
|
$ |
3,726 |
|
|
$ |
3,452 |
|
|
$ |
2,999 |
|
Tax benefit |
|
|
896 |
|
|
|
830 |
|
|
|
721 |
|
Stock-based compensation expense, net of tax |
|
$ |
2,830 |
|
|
$ |
2,622 |
|
|
$ |
2,278 |
|
The Company amortizes the unearned stock-based compensation expense over the remaining vesting period of approximately three years for unvested stock options and five years for unvested RSU's. The following table shows the unearned stock-based compensation expense for unvested stock options and unvested RSU's:
|
|
December 31, 2025 |
|
|
|
|
(Dollars in thousands) |
|
|
Unearned stock-based compensation expense for unvested stock options |
|
$ |
5,049 |
|
Unearned stock-based compensation expense for unvested RSU's |
|
|
5,914 |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Feb 28, 2025 | |
| 2023 | Feb 27, 2024 | |
| 2022 | Feb 24, 2023 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.